SCHEMBL5887243

SCHEMBL5887243

CCCCCCCCNC(=O)c1ccc(-n2c(=O)ccc3c(C)nc(NCc4ccco4)nc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
HPGD P15428 6/20 0.44
MAPT P10636 4/20 0.44
KDM4E B2RXH2 3/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
CYP2C9 P11712 4/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HTT P42858 1/20 0.43
CYP1A2 P05177 3/20 0.43
CYP2C19 P33261 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
TSHR P16473 1/20 0.43
GAA P10253 1/20 0.42
CYP2D6 P10635 2/20 0.41
CYP3A4 P08684 1/20 0.41
TP53 P04637 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL5887416 0.90 TDP1 (0.41) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5887028 0.90 TDP1 (0.52) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5887206 0.88 ALDH1A1 (0.40) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5887208 0.88 KMT2A (0.42) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5886962 0.87 NAAA (0.46) MAPTGAATP53L3MBTL1NAAA
SCHEMBL5886932 0.87 MAPT (0.46) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5887628 0.86 L3MBTL1 (0.45) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5887092 0.86 MAPT (0.46) ALDH1A1HPGDMAPTKMT2AMEN1
SCHEMBL5886726 0.86 TDP1 (0.43) ALDH1A1HPGDMAPTKDM4EKMT2A
SCHEMBL5886764 0.86 TDP1 (0.47) ALDH1A1HPGDMAPTKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US claimed
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors PHARMACIA ITALIA S.P.A. 2004-01-15 US claimed
US-7019002-B2 Substituted on 8th position with benzoic acid, ester or amide groups; anticancer agents PHARMACIA & UPJOHN, S.P.A. (IT) 2006-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009993-A1 Pyridopyrimidinones derivatives as telomerase inhibitors TERT, TERF2, TERF2IP ALDH1A1 1860/4885HPGD 1371/4885MAPT 1614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.